Literature DB >> 9286901

Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.

J R Kersten1, T J Schmeling, P S Pagel, G J Gross, D C Warltier.   

Abstract

BACKGROUND: The authors tested the hypothesis that isoflurane directly preconditions myocardium against infarction via activation of K(ATP) channels and that the protection afforded by isoflurane is associated with an acute memory phase similar to that of ischemic preconditioning.
METHODS: Barbiturate-anesthetized dogs (n = 71) were instrumented for measurement of systemic hemodynamics. Myocardial infarct size was assessed by triphenyltetrazolium chloride staining. All dogs were subjected to a single prolonged (60 min) left anterior descending coronary artery (LAD) occlusion followed by 3 h of reperfusion. Ischemic preconditioning was produced by four 5-min LAD occlusions interspersed with 5-min periods of reperfusion before the prolonged LAD occlusion and reperfusion. The actions of isoflurane to decrease infarct size were examined in dogs receiving 1 minimum alveolar concentration (MAC) isoflurane that was discontinued 5 min before prolonged LAD occlusion. The interaction between isoflurane and ischemic preconditioning on infarct size was evaluated in dogs receiving isoflurane before and during preconditioning LAD occlusions and reperfusions. To test whether the cardioprotection produced by isoflurane can mimic the acute memory of ischemic preconditioning, isoflurane was discontinued 30 min before prolonged LAD occlusion and reperfusion. The mechanism of isoflurane-induced cardioprotection was evaluated in two final groups of dogs pretreated with glyburide in the presence or absence of isoflurane.
RESULTS: Myocardial infarct size was 25.3 +/- 2.9% of the area at risk during control conditions. Isoflurane and ischemic preconditioning produced significant (P < 0.05) and equivalent reductions in infarct size (ischemic preconditioning alone, 9.6 +/- 2.0; isoflurane alone, 11.8 +/- 2.7; isoflurane and ischemic preconditioning, 5.1 +/- 1.9%). Isoflurane-induced reduction of infarct size also persisted 30 min after discontinuation of the anesthetic (13.9 +/- 1.5%), independent of hemodynamic effects during LAD occlusion. Glyburide alone had no effect on infarct size (28.3 +/- 3.9%), but it abolished the protective effects of isoflurane (27.1 +/- 4.6%).
CONCLUSIONS: Isoflurane directly preconditions myocardium against infarction via activation of K(ATP) channels in the absence of hemodynamic effects and exhibits acute memory of preconditioning in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286901     DOI: 10.1097/00000542-199708000-00024

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  85 in total

1.  Age-associated differences in gene expression in response to delayed anesthetic preconditioning.

Authors:  C Zhong; N Fleming; X Lu; P Moore; H Liu
Journal:  Age (Dordr)       Date:  2011-10-19

Review 2.  Volatile anesthetic-induced cardiac preconditioning.

Authors:  Anna Stadnicka; Jasna Marinovic; Marko Ljubkovic; Martin W Bienengraeber; Zeljko J Bosnjak
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

Review 3.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

4.  Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway.

Authors:  Danijel Pravdic; Filip Sedlic; Yasushi Mio; Nikolina Vladic; Martin Bienengraeber; Zeljko J Bosnjak
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 5.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 6.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

7.  Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat.

Authors:  Xiaoxu Shen; Niraj Bhatt; Jianhong Xu; Tao Meng; Miguel A Aon; Brian O'Rourke; Dan E Berkowitz; Sonia Cortassa; Wei Dong Gao
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

8.  The use of a volatile anesthetic regimen protects against acute normovolemic hemodilution induced myocardial depression in patients with coronary artery disease.

Authors:  Sratwadee Lorsomradee; Suraphong Lorsomradee
Journal:  Asian J Transfus Sci       Date:  2009-01

9.  Effect of propofol on cardiac function and gene expression after ischemic-reperfusion in isolated rat heart.

Authors:  Youn Jin Kim; Hae Ja Lim; Sung Uk Choi
Journal:  Korean J Anesthesiol       Date:  2010-02-28

10.  Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.

Authors:  Tarik Asselah; Ivan Bièche; Ingrid Laurendeau; Michelle Martinot-Peignoux; Valerie Paradis; Dominique Vidaud; Dominique-Charles Valla; Pierre Bedossa; Patrick Marcellin; Michel Vidaud
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.